Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2010 3
2011 4
2012 2
2013 4
2014 7
2015 5
2016 6
2017 3
2018 1
2019 1
2023 0

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Results by year

Filters applied: . Clear all
Page 1
The fat embolism syndrome as a cause of paraplegia.
Peters ST, Witvliet MJ, Vennegoor A, Ten Tusscher B, Boden B, Bloemers FW. Peters ST, et al. Among authors: vennegoor a. SAGE Open Med Case Rep. 2018 Jul 20;6:2050313X18789318. doi: 10.1177/2050313X18789318. eCollection 2018. SAGE Open Med Case Rep. 2018. PMID: 30046449 Free PMC article.
MRI pattern in asymptomatic natalizumab-associated PML.
Wattjes MP, Vennegoor A, Steenwijk MD, de Vos M, Killestein J, van Oosten BW, Mostert J, Siepman DA, Moll W, van Golde AE, Frequin ST, Richert ND, Barkhof F. Wattjes MP, et al. Among authors: vennegoor a. J Neurol Neurosurg Psychiatry. 2015 Jul;86(7):793-8. doi: 10.1136/jnnp-2014-308630. Epub 2014 Sep 9. J Neurol Neurosurg Psychiatry. 2015. PMID: 25205744
PML-IRIS during Fingolimod Diagnosed after Natalizumab Discontinuation.
Killestein J, Vennegoor A, van Golde AE, Bourez RL, Wijlens ML, Wattjes MP. Killestein J, et al. Among authors: vennegoor a. Case Rep Neurol Med. 2014;2014:307872. doi: 10.1155/2014/307872. Epub 2014 Nov 23. Case Rep Neurol Med. 2014. PMID: 25506447 Free PMC article.
MRI characteristics of early PML-IRIS after natalizumab treatment in patients with MS.
Wattjes MP, Wijburg MT, Vennegoor A, Witte BI, de Vos M, Richert ND, Uitdehaag BM, Barkhof F, Killestein J; Dutch-Belgian Natalizumab-associated PML study group. Wattjes MP, et al. Among authors: vennegoor a. J Neurol Neurosurg Psychiatry. 2016 Aug;87(8):879-84. doi: 10.1136/jnnp-2015-311411. Epub 2015 Sep 14. J Neurol Neurosurg Psychiatry. 2016. PMID: 26369555
Drug interference in immunogenicity assays depends on valency.
Rispens T, Hart MH, Ooijevaar-de Heer P, van Leeuwen A, Vennegoor A, Killestein J, Wolbink GJ, van der Kleij D. Rispens T, et al. Among authors: vennegoor a. J Pharm Biomed Anal. 2013 Nov;85:179-85. doi: 10.1016/j.jpba.2013.07.022. Epub 2013 Jul 30. J Pharm Biomed Anal. 2013. PMID: 23954437
Natalizumab drug holiday in multiple sclerosis: poorly tolerated.
Killestein J, Vennegoor A, Strijbis EM, Seewann A, van Oosten BW, Uitdehaag BM, Polman CH. Killestein J, et al. Among authors: vennegoor a. Ann Neurol. 2010 Sep;68(3):392-5. doi: 10.1002/ana.22074. Ann Neurol. 2010. PMID: 20661928
26 results